A Minimized Fc Binding Peptide from Protein A
Induces Immunocyte Proliferation and Evokes
Th1-Type Response in Mice
1
Pratima Sinha,
1
Jayati Sengupta, and Prasanta K. Ray
2
Immunotechnology Section, Bose Institute, Calcutta, 700 054, India
Received January 28, 1999
It is now well established that PA is a potent biological
response modifier, showing simultaneously antitumor,
antitoxic, anticarcinogenic, antifungal, antiparasitic
and immunomodulatory properties. Since PA is a for-
eign protein, it is quite logical to assume that it may be
cleaved into smaller peptide fragments in vivo which
may be responsible for biological activities of whole PA
molecule. The present study was undertaken to dissect
out the structural entities of PA responsible for its bio-
logical properties. Protein A (PA) of Staphylococcus au-
reus has a unique property of binding with immuno-
globulins. On the basis of molecular modeling and
energy minimization studies a 20-mer tryptic fragment
(theoretical) was predicted to retain IgG binding capac-
ity which has been verified by immunoblot. This peptide
sequence was selected to carry out experimental studies
to show its functional mimicry of PA. We observed in the
sera of 20-mer peptide treated mice that the concentra-
tions of IFN, TNF and IL1 increase to a peak level by
4 h; on the other hand, there was a decrease in IL4, IL6
and IL10 concentrations at the same time (4 h). The ratio
of IFN to IL4 showed Th1 type of response with the
peptide as well as with that of PA. The nitric oxide con-
centration in sera also increases and the peak increase
was in 6 h with both the peptide and PA. Cell cycle
analysis using FACS shows that 20 g dose of peptide
was non-toxic to thymocytes and spleenocytes; on the
other hand, it was immunoproliferative, shifting the thy-
mocytes and spleenocytes from G0/G1 to S phase of the
cell cycle. Further studies are in progress to evaluate
other biological properties of the peptide, to evaluate if
this peptide could be used as a substitute of PA to mimic
at least some of its biological activities. © 1999 Academic Press
Key Words: protein A; Fc binding; cytokines; Th1/Th2
pathway; immunomodulation.
Protein A (PA) was discovered from the cell wall
structure of Staphylococcus aureus, and utilized for a
long time in the laboratory for isolation and purifica-
tion of antibody molecules, specially IgG because of its
Fc binding property (1). This unique Fc binding prop-
erty of PA was also utilized to remove the “blocking
factors” from human cancer patients (2). Along with
IgG binding affinity, diverse array of biological func-
tions of PA were also demonstrated, such as antitumor
(3, 4), antitoxic (5), anticarcinogenic (6), immunomodu-
latory (7) antifungal (8) and antiparasitic effects (9).
Protein A has been demonstrated to act as B and T cell
mitogen (10, 11). It also induces production of different
cytokines (7), which are well known biological modula-
tors regulating cellular growth and differentiation (12)
on one hand, and apoptosis (13) on the other. Previous
observations from our laboratory (5, 6) have demon-
strated the antitoxic and anticancer properties of PA.
Moreover, PA has been demonstrated to activate phase
I and phase II biotransformation and detoxification
enzymes, thus abrogating the toxicity of different toxic
and carcinogenic chemicals (14, 15). During these stud-
ies (16) we have consistently observed that PA treat-
ment leads to an increase in both peripheral blood and
spleenic lymphocyte population. PA induced activation
of cell cycle shifting vis a vis proliferation in non-
Hodgkin’s lymphoma has also been reported (17).
The B-domain of protein-A, a 56 residue domain,
binds the Fc portion of IgGs with dissociation constant
(Kd) of about 10-50 nM (1). X-ray (18) and NMR (19)
studies showed that binding contacts are presented
from helix 1 (Lys7-His18) and helix 2 (Glu25-Asp36) of
the B-domain (PA).
It has been observed in recent years that in order to
effect a biological function, large molecular structure of
macromolecules may not be required always. The bio-
logical function may be mediated through a portion of
the whole molecule, normally called the active site or
by a proteolytically degraded small peptide molecule. A
particular type of contour, a globular structure, helical
1
This work was supported by DBT, Government of India, by
awarding a postdoctoral fellowship to Dr. Pratima Sinha.
2
To whom correspondence should be addressed at Immunotechnol-
ogy Section, Bose Institute, P-1/12 CIT Scheme VII M, Calcutta 700
054, India. Fax: 91-33-334-3886. E-mail: pkray@boseinst.ernet.in.
Biochemical and Biophysical Research Communications 258, 141–147 (1999)
Article ID bbrc.1999.0363, available online at http://www.idealibrary.com on
141 0006-291X/99 $30.00
Copyright © 1999 by Academic Press
All rights of reproduction in any form reserved.